Primary Pulmonary Coccidioidomycosis in Persons with Community Acquired Pneumonia in Endemic Areas
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Coccidioidomycosis is a frequent cause of community acquired pneumonia (CAP) in endemic areas of the United States. Methods This observational study included persons ≥ 14 years of age with CAP at Arizona or California study sites. The primary outcome was prevalence of PPC among patients with CAP. Secondary outcomes included predictors of PPC among those with CAP and clinical improvement in PPC. Associations between the SAnds-PPC clinical score over time and receipt of antifungal therapy among those with PPC were analyzed in a linear mixed model. Results Among 496 participants with CAP, the prevalence of PPC was 23.4% (95% CI: 19.9, 27.3). The odds of having PPC decreased for each year increase in age (odds ratio [OR]: 0.98; 95% CI: 0.97, 1.00); was lower for females than males (OR: 0.55; 95% CI: 0.33, 0.93); and higher for Hispanic ethnicity versus non-Hispanic ethnicity (OR: 1.98; 95% CI: 1.08, 3.64) Among 215 participants with PPC, a 50% reduction in the SAnds-PPC score (clinical response) was achieved by 67% of participants by Day 85, respectively. A linear mixed model controlling for visit, age, site, ethnicity, race and asthma history did not detect a difference in the average SAnds-PPC scores over time between participants who did and did not receive antifungal therapy (Parameter Estimate 0.79; 95% CI: -0.09, 1.67). Conclusions This study ascertained a high prevalence of coccidioidomycosis among patients with CAP in endemic areas. This study was not designed to definitively determine the impact of antifungal therapy for PPC.
Source: Open Forum Infectious Diseases
DOI: 10.1093/ofid/ofag749
Authors: Jonathan Hien Truong, Arash Heidari, Royce H Johnson, Aung K Htoo, Soe Win, John N Galgiani, Fariba M Donovan, Aneesh Narang, Mohamed Fayed, Neil M Ampel, George R Thompson III, Alison Wall, Alice Henning, Grace N Davis, Yashika C Johnson, Susanna Naggie, Emmanuel B Walter, for the Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis (SAnds-PPC) Study Group, Rana Shenoy, Armen Arshakyan, David Bronstein
Institutions: Kaiser Permanente, Dignity Health, Morehouse School of Medicine, University of California, Los Angeles, Kern Medical Center, University of Arizona, BIO5 Institute, University of Arizona College of Medicine- Phoenix, University of California, San Francisco, University of California Davis Medical Center, Emmes (United States), Duke University, Duke Clinical Research Institute
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,053
OpenAlex ID: W7236865626
